Cdymax (india) Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PALBOCICLIB (NON-STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 33055.
Remarkably, this DMF maintains an Active status since its submission on August 14, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 12, 2018, and payment made on September 06, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II